BC
Brunswick Corporation
BC's fundamentals are strong, but it looks expensive: trading at 23x earnings, above its usual 14x. Analysts expect strong earnings growth.
BC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Stable |
BC's profitability is currently healthy, and its revenue, cash flow and balance sheet are stable.
BC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $31.76 | -58% |
| Fair | 14x | $45.28 | -41% |
| Forward | 14x | $76.50 | — |
| Expensive | 21x | $69.06 | -9.7% |
| Current | 23x | $76.50 | — |
Historical ranges are pointers, not guarantees.
BC's PE is in its expensive range at 23x. If earnings grow as analysts expect, today's price would be 14x next year's earnings, in its fair range.
BC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BC, with profitability improving.
BC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.33 | +63% |
| Q3 2026 | $3.27 | +$6.88 |
| Q2 2026 | -$1.27 | -295% |
| Q1 2026 | -$2.06 | -266% |
| Q4 2025 | -$2.08 | -208% |
| Q3 2025 | -$3.61 | -190% |
| Q2 2025 | $0.65 | -87% |
| Q1 2025 | $1.24 | -77% |
| Q4 2024 | $1.93 | -68% |
BC has returned to profit: it earned $3.27 per share over the past year, after losing money the year before.
BC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.5B | +6.9% |
| Q2 2026 | $1.6B | +7.7% |
| Q1 2026 | $1.4B | +13% |
| Q4 2025 | $1.3B | +15% |
| Q3 2025 | $1.4B | +6.8% |
| Q2 2025 | $1.4B | +0.2% |
| Q1 2025 | $1.2B | -10% |
| Q4 2024 | $1.2B | -15% |
BC's revenue is recovering but still below its 2022 peak: $1.5B last quarter, up 6.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.2% | +25 points |
| Q2 2026 | 8.3% | +1.2 points |
| Q1 2026 | 3.6% | -1 points |
| Q4 2025 | 3.1% | +8 points |
| Q3 2025 | -18% | -26 points |
| Q2 2025 | 7.1% | -3.8 points |
| Q1 2025 | 4.6% | -3.5 points |
| Q4 2024 | -4.8% | -13 points |
BC's operating margin was 7.2% last quarter, up 25 points from the same quarter a year ago.
BC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $136.4M | +28% |
| Q2 2026 | $272.4M | +0.4% |
| Q1 2026 | -$121.3M | -$56.2M |
| Q4 2025 | $83.6M | -70% |
| Q3 2025 | $106.5M | +239% |
| Q2 2025 | $271.3M | +66% |
| Q1 2025 | -$65.1M | +$142.3M |
| Q4 2024 | $276.1M | +22% |
BC still generates free cash flow, though less than at its 2020 peak: $371M over the past year.
BC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -400K shares |
| 1 year | -0.9% | -600K shares |
| 3 years | -7% | -4.9M shares |
| 5 years | -17% | -13.2M shares |
| Available history | -24% | -20.5M shares |
BC has 65M diluted shares, down 0.9% from a year ago, with $75M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $28.8M |
| Q2 2026 | $15M |
| Q1 2026 | $16.2M |
| Q4 2025 | $15M |
| Q3 2025 | $21.9M |
| Q2 2025 | $17.5M |
| Q1 2025 | $25.6M |
| Q4 2024 | $10M |
BC spent $75M buying back its own shares over the past year, about the same as the year before.
BC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.8x | Moderate |
| Q2 2026 | 6.5x | High |
| Q1 2026 | 8.1x | High |
| Q4 2025 | 7.3x | High |
| Q3 2025 | 12.2x | High |
| Q2 2025 | 4.0x | Elevated |
| Q1 2025 | 4.0x | High |
| Q4 2024 | 3.5x | Elevated |
BC's net debt is about 2.8 years of its operating earnings (EBITDA), down from 12 years a year ago.
BC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.3 | Neutral |
| Stochastic | 65.3 | Neutral |
BC's weekly RSI is 53 (neutral) and its Stochastic is 65 (neutral).
BC PE vs Consumer Cyclical Sector
| Metric | BC | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 18x | 30% above |
| PE % | 87 | 47 | 40 pts above |
BC is trading at 23x earnings, a 30% premium to the Consumer Cyclical sector's median of 18x.
BC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $69.2 | 11% above |
| 20 week MA | $74.2 | 3.1% above |
| 50 week MA | $77.4 | 1.2% below |
| 100 week MA | $68.6 | 11% above |
| 200 week MA | $75.3 | 1.6% above |
BC's trend is mixed: it's above four of its five weekly moving averages, and 1.6% above its 200-week average.
BC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $60.8 | $81.5 | +34% |
| 2021 | $81.5 | $96.9 | +19% |
| 2022 | $96.9 | $71.4 | -26% |
| 2023 | $71.4 | $96.8 | +35% |
| 2024 | $96.8 | $64.7 | -33% |
| 2025 | $64.7 | $76.1 | +18% |
| 2026 YTD | $76.1 | $76.5 | +0.5% |
BC has finished higher in four of the last six years. It's up 0.5% so far in 2026.